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ABSTRACT. This study aimed at assessing the cytotoxicity of Eremomastax speciosa crude extract on NIH-
3T3 fibroblast cell lines and reporting the chemical constituents in the extract. The MTT assay on NIH-3T3 
cells showed a significantly lower (p < 0.05) inhibition from E. speciosa (IC50 > 30 µg/mL) compared to 
cyclohexamide (IC50 > 0.8 µg/mL). This result validates the non-toxicity observed with the use of E. speciosa on 
normal cells at low to moderate doses. Four compounds were isolated and identified from their EIMS as well as 
1D and 2D NMR spectroscopic data namely hydroxyandrographolide (1), stigmasterol glucoside (2), (Z)-4-
coumaric acid 4-O-β-D-apiofuranosyl-(1’’→2’)-O-β-D-glucopyranoside (3) and 5-methoxy-4,4′-di-O-methyl- 
secolariciresinol-9′-monoacetate (4). These compounds are isolated from this species for the first time. Thirteen 
volatile constituents were detected in the extract using gas chromatography mass spectrometry (GC-MS). Besides 
6,10,14-trimethy-2-pentadecanone (12.63%), mostly fatty acid esters were detected in high amounts notably ethyl 
hexadecanoate (16.00%), ethyl-9,12,15-octadecatrienoate (11.51%) and 9,12-octadecadienoic acid ethyl ester 
(8.05%). This study revealed many unsaturated fatty acid esters in E. speciosa and is noteworthy that ω-3 and ω-6 
fatty acid esters were predominant, hence an added nutritional value to this plant.  
  




Eremomastax speciosa (Hochst.) Cufod is a species of plants belonging to the Acanthaceae 
family [1, 2]. E. speciosa is widely distributed in West Africa where it is used traditionally, 
especially in Nigeria and Cameroon for various medicinal purposes. It is commonly used in 
pediatric care for conditions such as diarrhea, jaundice and fever [3]. Women of reproductive 
age in the Southern Regions of Nigeria and Cameroon use these leaves to enhance fertility and 
arrest postpartum bleeding [4, 5]. Reports have also shown an improved effect on male sexual 
behavior [6]. It is also known as the blood tonic plant due to its erythropoeitic properties [7]. E. 
speciosa is known locally as ‘Ikpo Ikong’, ‘Mbidmbid Ukebe’ amongst the Efiks and Ibibio 
tribes in Southern Nigeria. Other local names involve ‘Oyun’ in Yoruba, ‘Esinyin’ in Hausa and 
‘Nkwukwo’ in Ibos [8]. In Cameroon, it is known as “Ntamir” in the Nso tribe, ‘Pang ndjenit’ 
(meaning ‘red on one side’) amongst the Bamileke, ‘purple leaf’ in pidgin English [8, 9], 
‘mbezamou’ in Bafanji and ‘bghah’ in Mbum tribe. E. speciosa has well documented biological 
activities such as anti-ulcerative properties on the lining of the stomache [9, 10]. Its leaves have 
been reported to have anti-anaemic properties and antimicrobial activity against Candida 
albicans, Escherichia coli and Staphylococcus aureus [11] as well as strong oxidative 
scavenging properties against hydrogen peroxide and superoxide anion [12]. Though it is 
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evident that these medicinal attributes are because of active biomolecules they contain [5], few 
studies exist on the chemical characterisation and on the bioactive molecules from this plant 
species. It is necessary to provide scientific basis for the therapeutic property of medicinal plants 
to avoid intoxication and poisoning and to improve safety and optimization of formulations [13]. 
It is therefore necessary to investigate bioactive molecules with potential pharmacological 
properties contained in medicinal plants. In this work, methanol extract of leaves of E. speciosa 
was obtained and characterized by GC-MS. Column chromatography was used to isolate major 
bioactive compounds from this extract. 
EXPERIMENTAL 
 
General experimental procedures. Column chromatography was carried out on silica gel (70-
230 mesh, Merck). Thin-layer chromatography (TLC) was performed on silica gel precoated 
plates (Merck, PF254, 20x20, 0.25 mm). TLC plates were revealed using ceric(IV) sulfate and 
H2SO4 10% spray reagent. 
1H NMR spectra were recorded in deuterated solvents such as 
CD3OD and DMSO with TMS as internal standard at 400 MHz on Bruker Avance-400. The 
13C 
NMR spectrum was recorded at 100 MHz using CD3OD and DMSO. EI-MS and was obtained 
with a JEOL JMS-600H mass spectrometer. Optical densities for the bioassay of cytotoxicity 
screening were measured on a Thermo Scientific Multiskan FC, Vantaa, Finland 
spectrophotometer. GC-MS was done on a Hewlett-Packard 5890 (Bunker Lake Blvd, Ramsey, 
MN) gas chromatograph coupled to JEOL MS-600H mass spectrometer. 
 
Plant material. The plant material was collected from Akai Effa in Calabar municipality, River 
State, Nigeria, during the month of June-August 2016, authenticated and compared with an 
existing herbarium voucher specimen in the herbarium unit of the Department of Botany, 
Faculty of Sciences in the University of Calabar, Nigeria with voucher specimen: 
Herb/Bot/ucc/363.   
 
Extraction and isolation. The leaves of E. speciosa were dried in a shed and grounded to 
powder. 1 kg of plant powder was then extracted by maceration with methanol (1:10, w/v) for 
48 h at the room temperature. The superrnatant in each extraction was filtered out and the 
solvent removed using a rotary evaporator to yield crude extract. This process was repeated 
three times. From this process, a crude MeOH extract of E. speciosa (20.5 g) was obtained.  
A portion (10 g) of the MeOH extract of E. speciosa (extract obtained in larger amount) 
was subjected to column chromatography on silica gel using DCM-MeOH (0-100%) gradient 
with increasing polarity to give 35 fractions which were regrouped into 4 major fractions F1 
(200 mg), F2 (550 g), F3 (4 g) and F4 (2.5 mg). Fraction F2 was rechromatographed on a silica 
gel using a DCM-MeOH (25-30%) gradient to afford compound 3 (13.5 mg) which was 
identified as (Z)-4-coumaric acid 4-O-β-D-apiofuranosyl-(1’’→2’)-O-β-D-glucopyranoside 
[14]. Fraction F4 was purified on silica gel column using DCM-MeOH (50:50. v/v) isocratic 
gradient to give 15 subfractions. These obtained subfractions were crystallized on standing and 
were filtered out to give E-7 (65 mg) identified as a mixture of compound 1, 
hydroxyandrographolide [15] and compound 2, stigmasterol glucoside [16]. Purification of F3 
using DCM-MeOH (40-60%) in a silica gel column yielded compound 4 (8 mg) identified as 5-
methoxy-4,4′-di-O-methylsecolariciresinol-9′-monoacetate [17]. The structures of the isolated 
compounds were elucidated by the interpretation of their EIMS, 1D and 2D NMR data and by 
comparison with some data reported in literature.  
 
Gas chromatography–mass spectrometry (GC-MS) analysis of volatile constituents. The profile 
of the extract was firstly performed using gas chromatography-flame ionization detection (GC-
FID) on a Shimadzu GC-17 A (Shimadzu Corp., Kyoto, Japan) equipped with a SPB-5VR 
capillary column (30 m, 0.25 mmid). The carrier gas used was helium at a flow rate of 1 
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mL/min. The oven was kept initially at 60 °C for 3 min, then raised to 180 °C at a rate of 5 
°C/min and later to 300 °C at a rate of 7 °C/min. The split ratio of sample injection was 1:10. 
Information from the GC-FID profile was then used to run the GC-MS proper which was done 
on a Hewlett-Packard 5890 (Bunker Lake Blvd, Ramsey, MN) gas chromatograph coupled to 
JEOL MS-600H mass spectrometer and equipped with ZB-5MSVR capillary column (30 m, 
0.25 mm ID and 0.25 lm df). The analysis was done under the same conditions as for GC-FID. 
EI ion source was kept at 250 °C and 70 eV. 
  
Identification of compounds. For the identification of compounds, electronic mass spectral 
search on NIST library and by comparison with EIMS (electronic impact mass spectrometry) 
data reported in literature. Area normalization method for each peak was used to quantify 
constituents and reported in terms of percentage composition. 
 
Cytotoxic assay. 3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) (MTT) assay 
was used to evaluate the cytotoxic effect of E. speciosa crude extract on NIH-3T3 mouse 
fibroblast cells (ATCC, Manassas, USA) based on the principle of detecting viable 
mitochondrial cells. The MTT is reduced to a colored product by the activity of NAD(P)H-
dependent dehydrogenases and this indicates the level of energy metabolism in cells. Briefly 
cells were seeded in 96-well microplates with 1x104 cells in 0.1 mL of DMEM medium 
supplemented with 10% FBS and routinely cultured in a humidified incubator (37 °C in 5% 
CO2) for 24 h. After 24 h incubation, the old media was removed and various concentrations of 
E. speciosa (1–30 μg/mL), diluted in 200 μL of fresh media, were added. Then the medium was 
discarded and 200 μL of MTT solution (5 mg mL-1 in cyclohexemidine) was added to every well 
and re-incubated for an additional 4 h. 100 µL of DMSO was added to dissolve the formazan 
crystals formed. The plate was then read on a microplate reader at 570 nm (Spectra Max plus, 
Molecular Devices, CA, USA) for the extent of MTT reduction to formazan within cells. The 
cytotoxicity was recorded as concentrations causing 50% growth inhibition (IC50) on the NIH-
3T3 cell lines. The results (% inhibition) were processed by using Soft-Max Pro software 
(Molecular Devices, CA, USA) [13]. MTT solution with DMSO (without cells and medium) 
acted as a blank control in microplate reading while the cyclohexemidine-treated cells served as 
a drug control [18, 19].  
RESULTS AND DISCUSSION 
 
Isolated compounds. The crude extract of E. speciosa was subjected to column chromatography 
and some pure secondary metabolites were obtained and their structures elucidated from their 
EIMS and NMR data and by comparison with some literature data. The compounds were 
identified as hydroxyandrographolide [15] and stigmasterol glucoside [16], (Z)-4-coumaric Acid 
4-O-β-D-apiofuranosyl-(1’’→2’)-O-β-D-glucopyranoside [14], 5-methoxy-4,4′-di-O-methyl- 
secolariciresinol-9′-monoacetate [17], whose structures are given in Figure 1. 
 
Hydroxyandrographolide (1). 1H NMR (pyridine-d5, 600 MHz): δH ppm 2.04 (H-1), 1.97 (H-2), 
3.59 (H-3), 1.20 (H-5), 1.78 (H-6), 2.30 (H-7), 1.81 (H-9, d, J = 10.9 Hz), 1.22 (H-11), 4.62 (H-
12, d, J = 6.3 Hz), 3.12 (H-13, d, J = 6.3 Hz), 5.11 (H-14), 4.41 (H-15, d, J = 10.6 Hz), 
5.15/4.94 (H-17), 1.49 (H-18), 4.28 (H-19), 0.72 (H-20). 13C NMR (pyridine-d5, 150 MHz): δC 
ppm 37.4 (C-1), 29.1 (C-2), 79.9 (C-3), 43.3 (C-4), 55.5 (C-5), 47.7 (C-6), 38.7 (C-7), 148.8 (C-
8), 53.2 (C-9), 39.7 (C-10), 30.4 (C-11), 70.6 (C-12), 54.1 (C-13), 73.3 (C-14), 76.1 (C-15), 
177.3 (C-16), 107.4 (C-17), 23.8 (C-18), 64.3 (C-19), 15.5 (C-20). 
 
Stigmasterol glucoside (2). 1H NMR (pyridine-d5, 600 MHz): δH ppm 1.69 (H-1), 1.51 (H-2), 
3.47 (H-3), 1.78; 1.56 (H-4), 5.33 (H-6), 1.92 (H-7), 1.48 (H-8), 0.93 (H-9), 1.22 (H-11), 1.93 
(H-12), 1.11 (H-14), 1.48 (H-15), 1.70 (H-16), 1.07 (H-17), 0.65 (H-18), 0.96 (H-19), 1.98 (H-
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20), 0.90 (H-21), 5.15 (H-22, dd, 1H, J = 12 and 8 Hz), 5.02 (H-23, dd, 1H, J = 12 and 8 Hz), 
1.50 (H-24), 1.63 (H-25), 0.81 (H-26), 0.80 (H-27), 1.05 (H-28), 0.82 (H-29, t, 3H, J = 6.9 Hz), 
4.22 (H-1′, d, 1H, J = 7.8 Hz), 3.37 (H-2′), 3.12 (H-3′), 3.02 (H-4′), 3.64/3.07 (H-5′), 3.40 (H-
6′). 13C NMR (pyridine-d5, 150 MHz): δC ppm 36.8 (C-1), 31.3 (C-2), 76.9 (C-3), 38.2 (C-4), 
140.4 (C-5), 121.2 (C-6), 31.4 (C-7), 31.3 (C-8), 49.6 (C-9), 36.2 (C-10), 20.6 (C-11), 39.1 (C-
12), 41.8 (C-13), 56.2 (C-14), 23.8 (C-15), 28.7 (C-16), 55.3 (C-17), 11.8 (C-18), 18.8 (C-19), 
40.1 (C-20), 21.1 (C-21), 138.0 (C-22), 128.8 (C23), 50.6 (C-24), 28.7 (C-25), 20.8 (C-26), 18.4 
(C-27), 25.7 (C-28), 12.1 (C-29), 101.4 (C-1′), 73.5 (C-2′), 76.7 (C-3′), 70.9 (C-4′), 72.3 (C-5′), 
61.1 (C-6′). 
 
(Z)-4-Coumaric acid 4-O-β-D-apiofuranosyl-(1’’→2’)-O-β-D-glucopyranoside (3). 1H NMR 
(pyridine-d5, 600 MHz): δH ppm 7.91 (H-2), 6.97 (H-3, m, J = 8.5 Hz), 6.97 (H-5, m, J = 8.5 
Hz), 7.88 (H-6), 6.92 (H-7, d, J = 12.5 Hz), 6.67 (H-8, d, J = 12.5 Hz), 5.12 (H-1’, d, J = 7.1 
Hz), 4.20 (H-2’), 3.72 (H-3’), 3.56 (H-4’), 3.93 (H-5’), 3.83 (H-6’),5.31 (H-1’’, d, J = 2.5 Hz), 
4.42 (H-2’’), 4.88 (H-4’’), 3.48 (H-5’’). 13C NMR (Pyridine-d5, 150 MHz): δC ppm 163.2 (C-1), 
129.3 (C-2), 117.1 (C-3), 166.9 (C-4), 117.1 (C-5), 129.3 (C-6), 157.9 (C-7), 154.3 (C-8), 184.4 
(C-9), 101.4 (C-1’), 95.8 (C-2’), 75.9 (C-3’), 71.3 (C-4’), 76.7 (C-5’), 61.5 (C-6’), 103.6 (C-


























































































































Figure 1.  Structures of compounds isolated from E. speciosa. 
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5-Methoxy-4,4′-di-O-methylsecolariciresinol-9′-monoacetate (4). EIMS M+ 462; 1H NMR 
(pyridine d5, 600 MHz): δH ppm 6.81 (1H, s, H-2, d, J = 1.7 Hz), 7.16 (1H, s, H-6, d, J = 1.7 
Hz), 1.90 (2H, d, H-7), 1.09 (1H, m, H-8), 4.28/3.59 (2H, d, H-9), 7.19 (1H, s, H-2’),7.86 (1H, 
s, H-5’), 7.56 (1H, s, H-6’), 1.94 (2H, d, H-7’), 1.09 (1H, m, H-8’), 4.64/4.41 (2H, dd, H-9’), 
1.94 (3H, s, H-11’),4.03 (3 MeO), 4.03 (4 MeO), 4.03 (5 MeO), 4.05 (3’ MeO), 4.05 (4’ MeO). 
13C NMR (pyridine d5, 150 MHz): δC ppm 136.6 (C-1), 106.0 (C-2), 153.6 (C-3), 153.6 (C-4), 
153.8 (C-5), 106.0 (C-6), 35.8 (C-7), 42.4 (C-8), 62.6 (C-9), 132.6 (C-1’), 111.9 (C-2’), 147.3 
(C-3’), 148.8 (C-4’), 111.0 (C-5’), 121.0 (C-6’), 34.9 (C-7’), 39.6 (C-8’), 64.6 (C-9’), 172.1 (C-
10’), 21.1 (C-11’), 60.8 (3 MeO), 60.8 (4 MeO), 60.8 (5 MeO), 55.8 (3’ MeO), 56.1 (4’ MeO). 
  The compounds 1, 3 and 4 are reported from this species for the first time and this study is 
one of the prime isolation studies done on this specie despite its long-standing applications in 
traditional medicine. 
The compound 2 has been detected by GC-MS in the aqueous extract of E. speciosa but was 
not isolated [20]. Most chemical studies on this plant only report qualitative phytochemical 
screening using conventional reagents for qualitative test of classes of organic compounds. 
These qualitative tests may be misleading considering the colourful nature of the extracts that 
result from the aerial parts of this plant. It is therefore necessary to report these compounds 
isolated individually and characterized. This can justify some observed bioactivities as well as 
give orientations on expected bioactivities of this plant. These compounds either act in synergy 
or individually to confer the observed biological and therapeutic effects of E. speciosa. These 
compounds which are non-volatile occur in the plants alongside volatile compounds which can 
suitably be characterized using GC-MS.  
 
GC-MS profile. The GC-MS profile of the crude extract of E. speciosa enabled the 
characterisation of 13 volatile constituents reported on Table 1. 
 
Table 1. Volatile constituents of E. speciosa leave extracts detected by GC-MS with their percentage 
compositions. 
 
RT Compound name % Amount 
20.18 2,4-bis(1,1-dimethylethyl)-phenol 0.21 
28.06 6,10,14-Trimethy-l,2-pentadecanone 12.63 
30.86 Methyl hexadecanoate 4.21 
33.99 Ethyl hexadecanoate 16.00 
39.99 (Z,Z)- 9,12-Octadecadienoic acid methyl ester 1.83 
40.44 (Z,Z,Z)-9,12,15-Octadecatrienoic acid methyl ester 4.27 
43.39 9,12-Octadecadienoic acid ethyl ester 8.05 
43.64 Ethyl-9,12,15-octadecatrienoate 11.51 





63.69 3,7,11,15-Tetramethyl-2-hexadecen-1-ol 6.67 
67.95 i-Propyl-9,12-octadecenadienoate 5.87 
68.31 (E,E,Z)-1,3,12-Nonadecatriene-5,14-diol 3.71 
 
GC-MS was used to characterize the volatile constituents in the extract of E. speciosa. 
Mostly fatty acid esters were abundant. Ethyl hexadecanoate was the most abundant constituent 
identified in the extract with a percentage composition of 16.00%. Other major fatty acid esters 
were ethyl-9,12,15-octadecatrienoate (11.51%), 9,12-octadecadienoic acid ethyl ester (8.05%), 
i-propyl 9,12-octadecenadienoate (5.87%), (Z,Z,Z)-9,12,15-octadecatrienoic acid methyl ester 
(4.27%), methyl hexadecanoate (4.21%), ethyl octadecanoate (2.62%) and (Z,Z)-9,12-
octadecadienoic acid methyl ester (1.83%). Most of these detected fatty acids esters are ω-3 and 
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ω-6 fatty acids which can confer additional nutritive value to this plant. Previous studies 
reported 3,7,11,15-tetramethyl-2-hexadecen-1-ol, (E,E,Z)-1,3,12-nonadecatriene-5,14-diol, in an 
aqueous extract of E. speciosa [20] and generally corroborate with high amount of fatty acids 
reported herein. Other non-ester compounds included a fatty ketone 6,10,14-trimethy-2-
pentadecanone (12.64%) as one of the major constituents, two fatty alcohols 3,7,11,15-
tetramethyl-2-hexadecen-1-ol (6.67%), (E,E,Z)-1,3,12-nonadecatriene-5,14-diol (3.37%), a fatty 
epoxide 2,2-dimethyl-3-(3,7,12,16,20-pentamethyl-3,7,11,15,19-heneicosapentaenyl)-oxirane 
(1.09%) and a phenol derivative, 2,4-bis(1,1-dimethylethyl)-phenol (0.21%).  
 
Cytotoxicity of crude extract on NIH-3T3 fibroblasts. The cytotoxicity of the methanol extract of 
E. speciosa was evaluated on NIH-3T3 mouse fibroblast cells at concentrations of 1-30 µg/mL 
and cycloheximide was used as positive control. At the highest tested concentration of 30 
µg/mL, there was no appreciable activity of the crude extract compared to the positive control 
and the IC50 (concentration causing 50% growth inhibition on the NIH-3T3 fibroblasts) is 
therefore greater than 30 µg/mL as shown on Table 2. 
 
Table 2. Cytotoxicity of E. speciosa leave extract on NIH-3T3 fibroblasts. 
 
Sample Concentration  (µg/mL) % inhibition IC50 (µg/mL) 
Methanol fraction of E. speciosa 30 5 >30±0.0 
Cyclohexemide 30 71 0.8±0.0 
  Data are presented in mean±SD all samples were compared to cyclohexemidine (p < 0.05). 
 
The results from this screening of potential cytotoxicity of methanol fraction of E. 
speciosa on NIH-3T3 cell lines validates the non-toxicity associated with the use of E. speciosa 
leaves on living cells. This plant does not show any toxicological signs such as changes in 
appearance of internal organs or mortality even at a dose of 2 g/kg though minor changes were 
reported in hematological and biochemical parameters at the dose of 800 and 1600 mg/kg 
mostly in female animals [21]. The low toxicity of this plant is a favourable factor for its use in 




E. speciosa is a highly valued medicinal plant widely used in Africa and other tropical areas in 
the world. However, chemical studies on this plant remains scanty and there is a great necessity 
to reports its chemical constituents so as to guarantee its safety for use in traditional medicine. 
One of such important chemical study is the isolation of the bioactive compounds found in this 
plant and their characterisation. In this study, four secondary metabolites were characterised 
namely, hydroxyandrographolide (1), stigmasterol glucoside (2), (Z)-4-coumaric Acid 4-O-β-D-
apiofuranosyl-(1’’→2’)-O-β-D-glucopyranoside (3), 5-methoxy-4,4’-di-O-methyl- 
secolariciresinol-9’-monoacetate (4). These compounds are reportedly isolated from this species 
for the first time. The volatile constituents were characterized by GC-MS and were found to be 
mostly fatty acid esters. Cytotoxic potential of the methanol fraction shows a non-toxic effect of 
this plant at low doses thereby validating the non-toxicity associated with the use of this plant on 
normal cells. This study and most especially the isolated compounds can pave a way for future 
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